A Phase I study of the oral antimetabolite, CS-682,...

A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies

Jill Gilbert, Michael A. Carducci, Sharyn D. Baker, Elizabeth C. Dees, Ross Donehower
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Pages:
10
DOI:
10.1007/s10637-006-8219-0
Date:
November, 2006
File:
PDF, 287 KB
english, 2006
Conversion to is in progress
Conversion to is failed